Computational identification of quinolinol based estrogen receptor alpha antagonists as promising therapeutics for MCF 7 breast cancer

Abstract Breast cancer is a major cause of death from cancer worldwide, with the estrogen receptor alpha (ER-α) being an important therapeutic target for hormone-dependent MCF-7 breast cancer. The goal of this study was to use an computer-aided drug design (CADD) methodology to assess 22 quinolinol analogues as potential ER-α antagonists. The CADD methodology consisted of Gaussian field-based three-dimensional quantitative structure-activity relationship (3D-QSAR) analysis, pharmacophore modeling, a prediction of ADMET properties, molecular docking, molecular dynamics simulation (MD), and density functional theory (DFT) calculations. 3D-QSAR model had good predictive ability (R² = 0.9516, Q² = 0.5989, RMSE = 0.82, and Pearson's r = 0.845). The results of the pharmacophore analysis showed that the critical features for anticancer activity are an aromatic ring, hydrophobic, and hydrogen bond acceptor. According to the ADMET evaluation, compounds 1, 7, 25, and 13 have the highest potential to be developed into drug-like substances; compound 1 has the best ADMET score of 6.348. The molecular docking study of the ligands with ER-α (PDB ID: 3ERT) demonstrated that ligands 7, 1 and 25 exhibit significantly better binding affinities (-11.98, -11.48, and -11.04 kcal/mol, respectively) than 4-hydroxytamoxifen (-8.26 kcal/mol). The MD simulations showed that ligand 7 formed a considerably more compact and stable ER-α complex through consistent hydrogen bond interactions for the duration of the simulation (100 ns). The DFT analyses indicated ligand 7 had kinetic stability and significantly better electronic properties than the other ligands studied. ligand 7 for the development of breast cancer drugs that target ER-α.

Authors

Institutions

Publication Details

Journal
Discover Chemistry.
Published
2026-11-14
DOI
https://doi.org/10.1007/s44371-026-01046-0
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Computational identification of quinolinol based estrogen receptor alpha antagonists as promising therapeutics for MCF 7 breast cancer

Yogesh Vaishnav, Divya Pujari, Mayank Garhewal
3 links
Discover Chemistry.
Computational Drug Discovery Methods
article

Computational identification of quinolinol based estrogen receptor alpha antagonists as promising therapeutics for MCF 7 breast cancer

Yogesh Vaishnav, Divya Pujari, Mayank Garhewal
article en

Abstract

Abstract Breast cancer is a major cause of death from cancer worldwide, with the estrogen receptor alpha (ER-α) being an important therapeutic target for hormone-dependent MCF-7 breast cancer. The goal of this study was to use an computer-aided drug design (CADD) methodology to assess 22 quinolinol analogues as potential ER-α antagonists. The CADD methodology consisted of Gaussian field-based three-dimensional quantitative structure-activity relationship (3D-QSAR) analysis, pharmacophore modeling, a prediction of ADMET properties, molecular docking, molecular dynamics simulation (MD), and density functional theory (DFT) calculations. 3D-QSAR model had good predictive ability (R² = 0.9516, Q² = 0.5989, RMSE = 0.82, and Pearson's r = 0.845). The results of the pharmacophore analysis showed that the critical features for anticancer activity are an aromatic ring, hydrophobic, and hydrogen bond acceptor. According to the ADMET evaluation, compounds 1, 7, 25, and 13 have the highest potential to be developed into drug-like substances; compound 1 has the best ADMET score of 6.348. The molecular docking study of the ligands with ER-α (PDB ID: 3ERT) demonstrated that ligands 7, 1 and 25 exhibit significantly better binding affinities (-11.98, -11.48, and -11.04 kcal/mol, respectively) than 4-hydroxytamoxifen (-8.26 kcal/mol). The MD simulations showed that ligand 7 formed a considerably more compact and stable ER-α complex through consistent hydrogen bond interactions for the duration of the simulation (100 ns). The DFT analyses indicated ligand 7 had kinetic stability and significantly better electronic properties than the other ligands studied. ligand 7 for the development of breast cancer drugs that target ER-α.

Discover Chemistry.Vol. 3(1)
Guru Ghasidas Vishwavidyalaya (IN)
Good health and well-being
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon